申请人:Ford John
公开号:US20140206703A1
公开(公告)日:2014-07-24
The present invention relates to thienopyrimidine compounds which are potassium channel inhibitors. Pharmaceutical compositions comprising the compounds and their use in the treatment of arrhythmia are also described.
本发明涉及硫代嘧啶化合物,这些化合物是钾通道抑制剂。还描述了包含这些化合物的药物组合物及其在治疗心律失常中的用途。